Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy

Inclusion Criteria: * • Ability to understand read and sign the informed consent form. * Age between 30 and \<91 years * Ability to understand and follow instructions and study procedures * Willingness to comply with all study procedures and be available for the duration of the study * Ability to apply eye drop medication and willing to adhere to study medication regimen * Diagnosed with Fuchs dystrophy (clinically and on confocal microscopy) by the study investigator. * Pseudophakic FED with posterior capsule supported, suture-fixated, or sulcus-supported posterior chamber intraocular lens. * Fuchs dystrophy grades 2-4 on the Krachmer grading scale * Presence of central guttae deemed by the investigator to be the chief cause of visual symptoms, rather than cataract or corneal stromal edema * Clear peripheral cornea with an endothelial cell count \>1000 cells/mm2 on specular microscopy * Best corrected visual acuity in the study eye is 20/40 or worse at study enrollment * The patient is dissatisfied with current vision * The patient is otherwise to be offered a corneal graft * For females with reproductive potential, willingness to use highly effective contraception (e.g., hormonal contraception, barrier contraception, intrauterine device, or abstinence). * Indication for surgery may include cataract extraction and posterior chamber intraocular lens implantation Exclusion Criteria: * • Uncontrolled glaucoma (IOP \>25 mmHg) * Presence of seco…